Cynosure Group’s Steris STE Stock Holding History

Cynosure Group’s Portfolio STE Stock Details STE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-1,770	Closed	-$438K	–	513
2025 Q3	$438K	Hold	1,770	–	–	0.05%	243
2025 Q2	$425K	Buy	1,770 +263	+17%	+$61.2K	0.05%	244
2025 Q1	$342K	Buy	1,507 +150	+11%	+$33K	0.05%	252
2024 Q4	$279K	Buy	+1,357	New	+$298K	0.04%	333
2024 Q3	–	Sell	-1,742	Closed	-$382K	–	405
2024 Q2	$382K	Buy	+1,742	New	+$378K	0.06%	240

Other funds holding STE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

OAG

Orbis Allan Gray Hamilton, Bermuda $23.7B AUM 65.43% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

Select Equity Group New York $19.5B AUM 17.33% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Cynosure Group's STE Position: Q4 2025 in Review

Cynosure Group sold out of Steris (STE) in Q4 2025, closing a stake of 1,770 shares — an estimated $438K sold.

Cynosure Group first reported a position in STE in Q2 2024 and held it in 5 quarters. The position peaked at $438K in Q3 2025. 895 funds tracked by Wall St. Rank hold STE as of Q4 2025.

Cynosure Group reported no remaining Steris position as of Q4 2025 after selling out during the quarter.
Cynosure Group sold 1,770 Steris shares in Q4 2025, an estimated $438K.
Cynosure Group first reported a position in Steris in Q2 2024 and held it in 5 quarters.
Cynosure Group's Steris position peaked at $438K in Q3 2025.
895 funds tracked by Wall St. Rank held Steris as of Q4 2025.

Based on Cynosure Group's 13F filing for Q4 2025, filed 17 Feb 2026.